# Variable and conserved B cell epitopes of GII.4 human noroviruses

## TL;DR

This paper explores the B cell immune responses to GII.4 noroviruses, aiming to inform vaccine development against this highly variable virus.

## Contribution

The paper provides insights into conserved and variable B cell epitopes of GII.4 noroviruses, relevant for vaccine design.

## Key findings

- GII.4 noroviruses continuously produce new variants that evade immune responses.
- Understanding conserved and variable B cell epitopes may guide the development of broadly protective vaccines.

## Abstract

Norovirus is a leading cause of acute gastroenteritis worldwide, imposing a major burden on public health and healthcare systems. Despite its significant medical impact, no licensed vaccines or specific antiviral therapies are currently available. Norovirus vaccine development is complicated by several factors, including the extreme genetic and antigenic diversity. In particular, the predominant genotype GII.4 exhibits a continuous emergence of novel variants that can evade immune responses acquired from previous infections. In this manuscript, we will summarize the characteristics and current knowledge of the B cell responses elicited by conserved and variable GII.4 epitopes and discuss how these findings inform our understanding of responses to other pandemic norovirus genotypes. We also highlight how ongoing research in this area may provide critical insights for the development of broadly protective norovirus vaccines.